1992
DOI: 10.1016/0014-4827(92)90191-a
|View full text |Cite
|
Sign up to set email alerts
|

Calcyclin as a marker of human epithelial cells and fibroblasts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
53
0
1

Year Published

1994
1994
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 73 publications
(57 citation statements)
references
References 10 publications
3
53
0
1
Order By: Relevance
“…S100A6 was originally identified in Ehrlich ascites tumor (EAT) 1 cells (16,17). It was later established that S100A6 is mainly present in epithelial cells and fibroblasts (18). We found that in EAT cells of epithelial origin, S100A6 bound a protein with a molecular mass of about 30 kDa in a Ca 2ϩ -dependent manner (19).…”
mentioning
confidence: 93%
“…S100A6 was originally identified in Ehrlich ascites tumor (EAT) 1 cells (16,17). It was later established that S100A6 is mainly present in epithelial cells and fibroblasts (18). We found that in EAT cells of epithelial origin, S100A6 bound a protein with a molecular mass of about 30 kDa in a Ca 2ϩ -dependent manner (19).…”
mentioning
confidence: 93%
“…S100A6 was additionally identified and purified from murine Ehrlich ascites tumor cells (18) and Gou et al (19) described a correlation between the expression of S100A6 and the metastatic behavior of Ras-transformed NIH 3T3 fibroblasts. In benign tissues, S100A6 is expressed predominantly in fibroblasts and epithelial cells (20) but is also present in neuronal and smooth muscle cells. To elucidate the in vivo function(s) of S100A6 recent efforts focused on the identification of cellular binding partners and the metal-binding characteristics (21).…”
mentioning
confidence: 99%
“…The localization of S100A6 has been also studied in transformed (15,29) or normal tissues (20,30), and in cultured smooth muscle cells (31) using a polyclonal antibody. In this study we have reinvestigated the Ca 2ϩ -dependent subcellular localization of S100A6 using a novel highly specific monoclonal antibody and show that the protein localizes to the plasma * This work was supported by the Austrian Science Foundation (P-11845).…”
mentioning
confidence: 99%
“…S100A6 was identified from melanoma tissue samples by comparing melanocytic lesions from normal nevi [214]. S100A6 is most abundant in epithelial cells and fibroblasts but is also found, in smaller amounts, in other cell-types such as neurons, glial cells, smooth muscle cells, cardiac myocytes, platelets and lymphocytes [215,216](reviewed in [217]). S100A6 has been found elevated in a large number of cancer types which include colorectal cancer, pancreatic, hepato-cellular carcinoma, melanoma, lung cancer and gastric cancer [165,[218][219][220][221][222][223][224](reviewed in [217]).…”
Section: S100a6mentioning
confidence: 99%